Clinical Trials for Extensive Stage Lung Small Cell Carcinoma

Find clinical trials for extensive stage lung small cell carcinoma. Discover research opportunities and treatment options in your area.

11 Active Trials Found

Showing 11 trials on this page

Page 1 of 1

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

NCT ID: NCT04402788

The RAPTOR Trial is a clinical study looking at whether adding radiation therapy to the usual treatment with atezolizumab can help patients with extensive stage small cell lung cancer. This type of...

Recruiting

Phase: PHASE2 Type: interventional Locations: New Haven, Connecticut, United States, Lebanon, New Hampshire, United States +446 more

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

NCT ID: NCT05353439

This clinical trial is studying a new treatment approach for patients with small cell lung cancer that has returned after initial treatment. The researchers want to see if a combination of three dr...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Los Angeles, California, United States +13 more

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

NCT ID: NCT06287775

This clinical trial is exploring a new treatment approach for extensive stage small cell lung cancer, which is a type of lung cancer that has spread beyond the lungs. Researchers are testing a drug...

Recruiting

Phase: PHASE1 Type: interventional Locations: New Haven, Connecticut, United States, Duarte, California, United States +33 more

S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

NCT ID: NCT04155034

The S1827 (MAVERICK) clinical trial is studying whether using brain scans alone, instead of combining brain scans with preventive brain radiation, can help patients with small cell lung cancer live...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, New Haven, Connecticut, United States +489 more

Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

NCT ID: NCT04696575

This clinical trial is studying a new treatment approach for patients with extensive stage small cell lung cancer, a type of lung cancer that has spread widely in the body. The researchers want to ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Buffalo, New York, United States

Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

NCT ID: NCT04919382

This clinical trial is exploring a combination of two treatments—temozolomide, a chemotherapy drug, and atezolizumab, an immunotherapy drug—for patients with advanced small cell lung cancer that ha...

Recruiting

Phase: PHASE2 Type: interventional Locations: Iowa City, Iowa, United States, Columbus, Ohio, United States +3 more

Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial

NCT ID: NCT04728230

The PRIO trial is a research study looking at a new treatment approach for patients with extensive-stage small cell lung cancer (ES-SCLC), which is a type of lung cancer that has spread. This trial...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

NCT ID: NCT06769126

The PRISM Study is a clinical trial designed to find better ways to treat extensive stage small cell lung cancer (ES-SCLC) by using special tests called biomarker tests. These tests examine the tum...

Not yet recruiting

Phase: PHASE2 Type: interventional

Palliative Radiotherapy with Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer

NCT ID: NCT05244239

This clinical trial is looking at a new way to help patients with extensive stage small cell lung cancer, which means the cancer has spread beyond the lungs and is harder to treat. The researchers ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Atlanta, Georgia, United States, Atlanta, Georgia, United States +2 more

Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC

NCT ID: NCT06672133

This clinical trial is studying a new treatment approach for patients with extensive stage small cell lung cancer (ES-SCLC), a type of lung cancer that has spread beyond its original site. The tria...

Not yet recruiting

Phase: PHASE3 Type: interventional

Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation

NCT ID: NCT06110572

This clinical trial is investigating a new treatment approach for patients with extensive stage small cell lung cancer, which means the cancer has spread beyond the lungs. The study combines a medi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Nashville, Tennessee, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions